What is (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v is a sterile, isotonic intravenous solution used to replenish and maintain essential electrolyte balance in patients. Packaged in 500 mL Viaflo bags, this infusion is suitable for use in hospitals and critical care environments. It combines two vital electrolytes: potassium chloride, which helps maintain cardiac and neuromuscular function, and sodium chloride, which regulates fluid balance and osmotic pressure.
- Potassium Chloride (0.15% w/v): Helps restore intracellular potassium levels to prevent or treat hypokalemia.
- Sodium Chloride (0.9% w/v): Functions as a saline base to support fluid hydration and electrolyte stability.
This formulation is sometimes used alongside Calcium and Vitamin D3 supplementation for patients with multiple electrolyte disturbances or osteoporosis under clinical supervision.
How to use (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
This medication is administered intravenously and should only be used under the supervision of qualified healthcare professionals. It is typically delivered via controlled IV infusion using sterile equipment and appropriate dosage based on patient needs.
- Inspect the solution for clarity and bag integrity before administration.
- Use an aseptic technique when connecting the Viaflo bag to the IV line.
- Administer through a peripheral or central vein depending on potassium concentration and patient status.
- Adjust infusion rate carefully to avoid rapid potassium loading which can lead to cardiac complications.
- Always monitor serum electrolytes (especially potassium and sodium) before and during treatment.
The infusion may be co-administered with other agents like calcium gluconate or Vitamin D3 as per patient requirements, but compatibility must be verified before mixing.
Mode of Action (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
This medication is administered intravenously and should only be used under the supervision of qualified healthcare professionals. It is typically delivered via controlled IV infusion using sterile equipment and appropriate dosage based on patient needs.
- Inspect the solution for clarity and bag integrity before administration.
- Use an aseptic technique when connecting the Viaflo bag to the IV line.
- Administer through a peripheral or central vein depending on potassium concentration and patient status.
- Adjust infusion rate carefully to avoid rapid potassium loading which can lead to cardiac complications.
- Always monitor serum electrolytes (especially potassium and sodium) before and during treatment.
The infusion may be co-administered with other agents like calcium gluconate or Vitamin D3 as per patient requirements, but compatibility must be verified before mixing.
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v Interactions (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
This product may interact with several medications and medical conditions. Close monitoring is required when administered concurrently with other agents.
- ACE inhibitors (e.g., Lisinopril): Can raise serum potassium levels, increasing the risk of hyperkalemia.
- Potassium-sparing diuretics (e.g., Spironolactone): Additive effects can lead to dangerous potassium retention.
- Digitalis (e.g., Digoxin): Low potassium can potentiate digitalis toxicity, while high potassium may reduce efficacy.
- Corticosteroids: May enhance sodium retention and potassium loss.
- Calcium/Vitamin D3 Supplements: Co-administration requires monitoring for potential calcium-phosphate imbalance.
Avoid using other potassium-containing IV fluids or oral supplements without medical oversight. Compatibility with other IV drugs must be verified prior to mixing in the same line.
Dosage of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
The dosage of this infusion must be individualized based on clinical need, patient weight, renal function, and ongoing electrolyte monitoring. It should always be prescribed by a medical professional.
- Adult Dose: Typically 20–40 mEq of potassium per day via IV, not exceeding 10–20 mEq/hour via peripheral line or 40 mEq/hour via central line.
- Infusion Rate: Should not exceed 10 mEq/hr unless under cardiac monitoring.
- Sodium Chloride: Administered to maintain hydration and isotonic balance, generally aligned with fluid needs of 1.5–2.5 L/day in adults.
- Renal Impairment: Dosage must be reduced or avoided due to risk of hyperkalemia.
Frequent lab testing (potassium, sodium, BUN, creatinine) is critical to safely adjust infusion parameters.
Possible side effects of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
While generally safe when administered correctly, this solution may cause adverse effects, especially in cases of overdose or improper administration.
- Hyperkalemia: Characterized by muscle weakness, cardiac arrhythmias, and ECG changes. Life-threatening if not treated promptly.
- Fluid Overload: Can lead to edema, hypertension, or congestive heart failure, particularly in patients with cardiac or renal conditions.
- Injection Site Reactions: Includes vein irritation, thrombophlebitis, or localized inflammation.
- Electrolyte Imbalance: Incorrect dosing may trigger hyponatremia or acid-base disturbances.
In rare cases, anaphylactic reactions or hypersensitivity may occur. Immediate discontinuation and medical intervention are advised upon severe adverse events.
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v Contraindications (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
The following conditions contraindicate the use of this infusion product:
- Hyperkalemia: High serum potassium is a strict contraindication due to risk of cardiac complications.
- Severe Renal Impairment: Impaired potassium excretion may lead to dangerous retention levels.
- Addison's Disease: Increased potassium retention may worsen adrenal insufficiency.
- Uncontrolled Hypertension or Heart Failure: Fluid overload risk must be avoided.
- Hypersensitivity: Patients with known sensitivity to any component of the formulation.
Clinical discretion is required in elderly patients or those on medications affecting renal or electrolyte balance.
Storage of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v
Proper storage is crucial to maintain the sterility and efficacy of this intravenous solution.
- Store at 15°C to 25°C (59°F to 77°F) in a dry place away from direct sunlight.
- Do not freeze. Freezing can compromise the integrity of the plastic Viaflo bag and degrade active ingredients.
- Keep in original packaging until use to avoid contamination.
- Check expiry date and clarity of solution before administration—discard if cloudy or discolored.
- Do not use if the Viaflo bag is leaking, damaged, or improperly sealed.
As with all infusion solutions, unused portions should be discarded after opening. This product is for single-use only.
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v features an exceptional active ingredient renowned for its potent effects, comprising Potassium chloride, Sodium chloride. This powerful formulation provides a superior solution for addressing diverse health concerns. With 1.5g, 9g/L concentration and an easily manageable Infusion/Solution for, it remains a preferred option for countless individuals seeking effective treatment.
Introduction
All you need to know about (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v .
Welcome to Dwaey, specifically on (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v page.
This medicine contains an important and useful components, as it consists of Potassium chloride, Sodium chloride.
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v is available in the market in concentration 1.5g, 9g/L and in the form of Infusion/Solution for.
BAXTER HEALTH CARE LIMITED is the producer of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v and it is imported from UK,
The most popular alternatives of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v are listed downward .
-
Active Substance
Potassium chloride, Sodium chloride
-
Size
-
Indications
-
Type
-
Company
BAXTER HEALTH CARE LIMITED
Frequently Asked Questions
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v should be stored according to the instructions provided by BAXTER HEALTH CARE LIMITED.
In general, it is recommended to store (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v in a cool, dry place, away from direct sunlight
and out of the reach of children.
The duration of treatment with (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v may vary depending on the condition being treated
and the guidance of your healthcare provider. It is important to follow the prescribed treatment
plan and continue taking (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v for the recommended duration, even if your symptoms improve.
If you have any concerns or questions about the duration of treatment, consult your healthcare provider.
It is important to check with your healthcare provider or read the medication label for specific
instructions regarding alcohol consumption while taking (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v. Some medications, including
(BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v, may have interactions with alcohol that can reduce effectiveness, increase side
effects, or pose other risks to your health. It is best to follow the guidance provided by your
healthcare professional.
If you miss a dose of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v, take it as soon as you remember. However, if it is close
to the time for your next scheduled dose, skip the missed dose and continue with your regular dosing
schedule. Do not take a double dose to make up for a missed one unless advised by your healthcare provider.
No, do not stop taking (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v without consulting your healthcare provider, even if your
symptoms improve. It is important to complete the full course of treatment as prescribed. Stopping
the medication prematurely may lead to a relapse or incomplete resolution of the condition. If you
have concerns about the duration of treatment, consult your healthcare provider for guidance.
It is important to consult your healthcare provider before taking (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v if you are
pregnant or breastfeeding. They will be able to assess the potential risks and benefits based on your
specific situation. Please note that the safety and suitability of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v during pregnancy
or breastfeeding may depend on the active substance [Active Substance], concentration 1.5g, 9g/L,
and the specific recommendations of BAXTER HEALTH CARE LIMITED.
The effects of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v on your ability to drive or operate machinery can vary depending on
the active substance [Active Substance], concentration 1.5g, 9g/L, and individual factors.
Some medications may cause drowsiness, dizziness, or other side effects that can impair your judgment
or coordination. It is important to read the medication label or consult your healthcare provider to
understand any potential effects on your ability to perform tasks that require alertness.
The instructions for taking (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v with or without food may vary depending on the medication
and the recommendations of BAXTER HEALTH CARE LIMITED. Some medications may be more effective when taken with
food to enhance absorption or reduce stomach irritation, while others may need to be taken on an empty
stomach for optimal absorption. Read the medication label or consult your healthcare provider for specific instructions.
The use of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v in children or elderly individuals may depend on various factors, including
the specific medication, type Infusion/Solution for, and the recommendations of BAXTER HEALTH CARE LIMITED. Some
medications may have specific dosing instructions or precautions for these age groups. Consult your
healthcare provider or read the medication label for information regarding the safe and appropriate use
of (BAXTER) Potassium Chloride 0.15% w/v and Sodium Chloride 0.9% w/v in children or elderly individuals.
Dwaey
All medical information published on the Dwaey website aims to increase medical awareness and health education among users. However, it is not a substitute for professional medical advice. Always consult with a specialist doctor. We strongly advise against using any information or medicine found on the site without referring to your healthcare provider.
Related Products
0 Comments